PUREfi Wealth LLC Buys 322 Shares of CME Group Inc. $CME

PUREfi Wealth LLC boosted its stake in CME Group Inc. (NASDAQ:CME) by 40.5% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 1,117 shares of the financial services provider’s stock after purchasing an additional 322 shares during the quarter. PUREfi Wealth LLC’s holdings in CME Group were worth $308,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Webster Bank N. A. boosted its holdings in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares in the last quarter. Highline Wealth Partners LLC boosted its holdings in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares in the last quarter. Wayfinding Financial LLC bought a new stake in CME Group in the first quarter valued at $25,000. Cornerstone Planning Group LLC boosted its holdings in CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares in the last quarter. Finally, Golden State Wealth Management LLC boosted its holdings in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other news, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. The trade was a 4.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,043 shares of company stock worth $3,527,956 in the last 90 days. 0.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

CME has been the topic of several recent analyst reports. UBS Group cut their price target on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a report on Monday, September 8th. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research report on Saturday, September 27th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and raised their price objective for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. JPMorgan Chase & Co. raised their price objective on CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a research report on Thursday, September 25th. Finally, Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Six equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $274.15.

CME Group Price Performance

CME opened at $264.67 on Monday. The stock has a 50-day moving average price of $269.98 and a 200-day moving average price of $271.16. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $95.38 billion, a PE ratio of 25.62, a P/E/G ratio of 5.57 and a beta of 0.41. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.56 EPS. Sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is currently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.